Bruce Poulter MPH ’87


Bruce Poulter MPH ’87 writes, “Our business was awarded a half million dollar contract in late 2013 to conduct a Phase 2 Clinical Trial of the efficacy and safety of MDMA-Assisted Psychotherapy for 24 people with chronic treatment resistant PTSD. Marcela Ot’alora G.—my business partner and wife—is the principal investigator. We plan to complete the trial later this year… At this time our clinical site in Boulder, Colo., will be one of 10 or 12 sites for the anticipated FDA approval of Phase 3 Clinical Trials that will hopefully begin in 2016. Based on research to date, this is one of the most promising approaches for decreasing the suffering while increasing the quality of life for people with PTSD.”

Leave A Comment